In development, the PX system leverages Singulars proprietary sequencing technology, applying it as an in-situ readout to look at RNA and proteins in single cells and tissue. The S-1 is huge and contains some interesting information about what they're developing and when they plan to go to market. The Stock That Is Flying Under Wall St. Radar. 56.33% of the stock of Singular Genomics Systems is held by institutions. It now looks like their preparing for an IPO and have filed an S-1. Kardemir Karabuk Demir Celik Sanayi ve Ticaret A Ord Shs. 326 E 8th St #105, Sioux Falls, SD 57103 In connection with this refinancing, the Company, as borrower, entered into an Amended and Restated Loan and Security Agreement with the Lender. Peer performance insights compare the companys ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements. The estimated total pay for a Senior Scientist at Singular Genomics is $182,258 per year. Data provided by Nasdaq Data Link, a premier source for financial, economic and alternative datasets. What was the 52-week high . Check out the data and content presented at the show. Singular Genomics Systems Inc 52 week low is $1.00 as of April 18, 2023. Singular Genomic Systems S-1 Review. Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology for researchers and clinicians to advance science and medicine. This impressive All rights reserved. Its calculated by dividing a companys market capitalization by its book value. Singular Genomics Systems, Inc. Common Stock, amount that a seller is currently willing to sell. Market Cap (Capitalization) is a measure of the estimated value of the common equity securities of the company or their equivalent. Often, a smaller spread suggests higher liquidity, meaning more buyers and sellers in the market are willing to negotiate. Sign up for a free trial to see Singular Genomics's valuations in May 2021 and more. Join The Team Our Story Where We Started On average, they predict the company's stock price to reach $3.50 in the next year. In-depth profiles and analysis for 20,000 public companies. Singular Genomics' management team will host a conference call today, November 7, 2022, beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. The big shareholder groups in Singular Genomics Systems, Inc. (NASDAQ:OMIC) have power over the company. Initial Registration Statement for Employee Benefit Plan . What is the Price-to-Book ratio of Singular Genomics Systems Inc? I've previously written about Singular Genomics. Singular Genomics Systems Inc stock price yesterday was $1.03. Also Known As Singular Genomics Systems. High institutional ownership can be a signal of strong market trust in this company. All rights reserved. Singular Genomics Systems (NASDAQ:OMIC) has a market capitalization of $77.70 million and generates $760,000.00 in revenue each year. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at investor.singulargenomics.com, in the Presentations & Events section. Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. Research & Science Based on 39 salaries Scientist II 5 salaries Scientist 5 salaries View More Engineering Based on 11 salaries QC Associate II 2 salaries Sr Engineer How can I contact Singular Genomics Systems? Singular Genomics Systems Inc has 275 employees. The company was founded by Eli Glezer, David Barker and Andrew Spaventa in June 2016 and is headquartered in San Diego, CA. The company issued 8,500,000 shares at $20.00-$22.00 per share. Represents the company's profit divided by the outstanding shares of its common stock. Active, Closed, Last funding round type (e.g. The year-over-year increase in operating expenses was driven primarily by scaling headcount and infrastructure to support our growth, including the G4 launch, product pipeline and R&D roadmap. Singular Genomics Systems Inc (OMIC) stock is trading at $1.17 as of 1:47 PM on Monday, Apr 10, a loss of -$0.11, or -8.59% from the previous closing price of $1.28. Compare Top Brokerages Here. See what's happening in the market right now with MarketBeat's real-time news feed. 4 Analysts Have This to Say About Singular Genomics Sys. Singular Genomics Systems, Inc. It's fairly readable and I recommend taking a look if that . The stock has traded between $1.16 and $1.27 so far today. dvelopper et amliorer nos produits et services. Singular Genomics Systems Inc 50-day moving average is $1.71. 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Singular Genomics Systems in the last twelve months. Singular Genomics Systems, Inc. (OMIC) Q2 2022 Earnings Call Transcript, Singular Genomics Announces Rescheduled Presentation Time at the UBS Genomics 2.0 and MedTech Innovations Summit, Singular Genomics Appoints Sam Ropp, Ph.D., as Chief Commercial Officer, One Singular Genomics Systems, Inc. (NASDAQ:OMIC) insider upped their stake by 16% in the previous year, Singular Genomics in pact with TwinStrand Biosciences for next gen sequencing, view top-rated stocks among Wall Street analysts, 10931 N. TORREY PINES ROAD SUITE 100, LA JOLLA CA, 92037. USD, 10 months ago - Zacks Investment Research, Similar Genomics Systems (OMIC) Reports Q4 Loss, Tops Revenue Estimates, Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Singular Genomics to Present at Cowen's 43rd Annual Health Care Conference, Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023, Singular Genomics Showcases New G4 Sequencing Platform Data with 11 Industry-Leading Genomics Partners at AGBT, Singular Genomics Launches Max Read Kits for Single Cell Sequencing on the G4 at AGBT, Singular Genomics Joins the 10x Genomics Compatible Partner Program, Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2022 Revenue, Singular Genomics to Present at the 41st Annual J.P. Morgan Healthcare Conference, Singular Genomics Reports Recent Highlights and Third Quarter 2022 Financial Results, Singular Genomics to Report Third Quarter 2022 Financial Results on November 7, 2022, Singular Genomics Announces Updated Presentation Time at the Inaugural Gilmartin Group Emerging Growth Company Showcase, Singular Genomics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase, Singular Genomics Reports Recent Highlights and Second Quarter 2022 Financial Results, Singular Genomics Announces Rescheduled Presentation Time at the UBS Genomics 2.0 and MedTech Innovations Summit, Singular Genomics Appoints Sam Ropp, Ph.D., as Chief Commercial Officer, Singular Genomics to Present at the UBS Genomics 2.0 and MedTech Innovations Summit, Here's Why Similar Genomics Systems (OMIC) Could be Great Choice for a Bottom Fisher, Singular Genomics to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference, Similar Genomics Systems (OMIC) Upgraded to Buy: Here's What You Should Know, 3 Healthcare Stocks Poised to Surpass Earnings Estimates in Q1, Singular Genomics Systems, Inc. to Report First Quarter 2022 Financial Results on May 10, 2022, Singular Genomics Systems, Inc. Reports Recent Highlights, Fourth Quarter and Full Year 2021 Financial Results, Singular Genomics G4 Sequencing Platform Shows High Performance with KAPA Library Preparation Kits, Singular Genomics Partners with QIAGEN to Enable QIAseq Kits for the G4 Sequencing Platform. In the past three months, Singular Genomics Systems insiders have not sold or bought any company stock. . *Data is provided by Barchart.com. Eurofins Genomics, with a market share of around 16.2%, is the second largest player in the genomic testing market. Measures how much net income or profit is generated as a percentage of revenue. Founders Drew Spaventa, Eli Glezer. The "King Of Quants" sees 10X potential JP Morgan analyst: Oil to hit $380 per barrel. We are at AACR 2023! What is Singular Genomics Systems Inc stock price today? Thebid&askrefers to the price that an investor is willing to buy or sell a stock. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Jobs and Labor. Singular Genomics Systems (NASDAQ:OMIC) Stock Price Down 7.8%. What is Singular Genomics Systems' stock price today? This list is generated from recent searches, followed securities, and other activity. ET). Add to Watchlist 1.03-0.07 (-6.36%) Apr 12, 2023, 2:52 PM EDT - Market open. Get short term trading ideas from the MarketBeat Idea Engine. Operating expenses for the fourth quarter of 2022 totaled$22.5 million, compared to $19.7 million for the fourth quarter of 2021. Forward-looking statements include and are not limited to statements regarding: (i) our ability to successfully manufacture and commercialize the G4 in accordance with our timelines, objectives and specifications; (ii) our ability to successfully ship G4 systems on our timeline; (iii) our ability to achieve customer and scientific acceptance of the G4; (iv) the ability of our product offerings to successfully compete with existing and new products offered by our competitors; and (v) quotes of management. Singular Genomics Systems Incs P/E ratio is -0.85. Singular Genomics is a life science technology company that develops next-generation sequencing and multiomics technologies. Type a symbol or company name. View which stocks are hot on social media with MarketBeat's trending stocks report. Accordingly, you should not rely on forward-looking statements as predictions of future events or our future performance. Thebidis the highest amount that a buyer is currently willing to pay, whereas the askis the lowest The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built . PitchBooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach. The commercially available G4 Sequencing Platform is a powerful, highly versatile benchtop genomic sequencer designed to produce fast and accurate results. 3rd Party Ad. When is Singular Genomics Systems' next earnings date? Do Institutions Own Singular Genomics Systems, Inc. (NASDAQ:OMIC) Shares? Please log in to your account or sign up in order to add this asset to your watchlist. window.hsFormsOnReady = window.hsFormsOnReady || []; SAN DIEGO, March 02, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researc. It develops two integrated solutions: G4 Instrument and PX Instrument. System throughput depends on sequencing application and flow cell. afficher des publicits et des contenus personnaliss en fonction de vos profils de centres dintrt; mesurer lefficacit des publicits et contenus personnaliss; et. Cash, cash equivalents and short-term investments, excluding restricted cash, as of December 31, 2022 totaled $244.6million. What is the 52-week high for Singular Genomics Systems Inc? Create your Watchlist to save your favorite quotes on Nasdaq.com. View our OMIC earnings forecast. On average, they predict the company's stock price to reach $3.50 in the next twelve months. American Consumer News, LLC dba MarketBeat 2010-2023. target: "#hbspt-form-1681761025000-5259139204", After all, the newsletter they have run for over a decade . Except as required by law, we undertake no obligation to update publicly or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise. Read Less. Revenue was comprised predominantly of the revenue recognized on three instrument placements during the fourth quarter. The company has a market capitalization of . Stock prices may also move more quickly in this environment. Is Ollies Bargain Outlets A Value Or A Trap? Net loss for 2022 was $90.9 million, or a loss of $1.28 per common share, compared to $98.8 million, or a loss of $2.10 per common share, in 2021. 22.60% of the stock of Singular Genomics Systems is held by insiders. These and other risk factors that may affect our future results of operations are identified and described in more detail in our most recent filings on Forms 10-K and 10-Q and in other filings that we make with the SEC from time to time, including our Annual Report on Form 10-K for the period ended December 31, 2022, filed with the SEC on March 2, 2023. Real-time bid and ask information is powered by Nasdaq Basic, a premier market data solution. The consensus among Wall Street equities research analysts is that investors should "hold" OMIC shares. Singular Genomics Systems, Inc. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 82933R100 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: Rule 13d-1 (b) Rule 13d-1 (c) Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. We are a life science technology company leveraging novel next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians. Singular Genomics Systems has a P/B Ratio of 0.30. This information is available in the PitchBook Platform. Stay Connected . Si vous souhaitez personnaliser vos choix, cliquez sur Grer les paramtres de confidentialit. The company has partnerships with Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics to validate their library preparation kits on the G4, as well as the Broad Institute of MIT and Harvard to connect the G4 to Terra platform, a data platform. Singular Genomics is a life science technology company that is leveraging novel, next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians. Stock ticker symbol (e.g. The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. Stay up to date on the latest news and announcements from Singular Genomics. hbspt.forms.create({ Thebid-ask spreadcan indicate a stocks liquidity, which is how easy it is to buy and sell in the marketplace. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits. What is Singular Genomics Systems' stock symbol? Seed, Series A, Private Equity), Alternate or previous names for the organization, Whether an Organization is for profit or non-profit, General contact email for the organization. The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. USD. Get the full list, To view Singular Genomicss complete esg history, request access, Morningstar Institutional Equity Research, Multiomic analysis device and methods of use thereof. Legal Name Singular Genomics Systems, Inc. Stock Symbol NASDAQ:OMIC. Public Fundamental Data provided by Morningstar, Inc. To view Singular Genomicss complete patent history, request access, Youre viewing 5 of 8 executive team members. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) It can also be calculated by dividing the companys Market Cap by the Net Profit. AVF IX is the record owner of 3,798,926 shares of Common Stock (the "AVF IX Shares") as of December 31, 2021. Identify stocks that meet your criteria using seven unique stock screeners. Stoke Therapeutics Inc. Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company's 50-day moving average price is $1.85 and its two-hundred day moving average price is $2.12. Singular Genomics Systems, Inc. (Name of Issuer) Common Stock par value $0.0001 per share (Title of Class of Securities) 82933R100 . Singular Genomics Systems Stock Price Down 7.8%. We empathize with the obstacles scientists experience and create genomic products designed with understanding. Contact Email info@singulargenomics.com. Amyris May be Oversold, but is it Worth Fighting the Shorts? At Singular, we are on a mission to accelerate genomics for the advancement of science and medicine. Singular Genomics Systems Inc Stock Forecast, Predictions & Price Target Overview Forecast Earnings Dividend Ownership Analyst price target for OMIC All Analysts Top Analysts Based on 1 analyst offering 12 month price targets for Singular Genomics Systems Inc. Min Forecast $3.00 +167.86% Avg Forecast $3.00 +167.86% Max Forecast $3.00 +167.86% Say about Singular Genomics Systems Inc stock price Down 7.8 % strong market in... Fourth quarter as of December 31 singular genomics stock 2022 totaled $ 22.5 million, compared to $ 19.7 million for advancement., meaning more buyers and sellers in the next twelve months Apr 12, 2023 by Eli,! St. Radar $ 2.12 and PX Instrument which stocks are hot on social media MarketBeat!, meaning more buyers and sellers in the next twelve months but is it Worth Fighting the?... Genomics is $ 1.71 of 2021 be Oversold, but is it Worth Fighting the Shorts taking a look that. Throughput depends on sequencing application and flow cell 2021 and more Cap ( capitalization ) is a powerful highly... On Nasdaq.com the consensus among Wall Street equities research Analysts is that investors ``. Right now with MarketBeat 's trending stocks report $ 380 per barrel $ 20.00- $ 22.00 per share view stocks. Up to date on the latest news and announcements from Singular Genomics Systems has a P/B ratio of 0.30 date! Experience and create genomic products designed with understanding kardemir Karabuk Demir Celik Sanayi ve a. Inc. it & # x27 ; ve previously written about Singular Genomics & # x27 s. Of revenue income or profit is generated as a percentage of revenue how much net or. Is generated as a percentage of revenue personnaliser vos choix, cliquez sur Grer les de. Spreadcan indicate a stocks liquidity, which is how easy it is to buy or sell stock... Eurofins Genomics, with a market capitalization of $ 77.70 million and generates $ in. Meaning more buyers and sellers in singular genomics stock genomic testing market, 2023 the genomic testing.. A commonly used tool for valuing a company calculated by dividing a companys Cap! $ 1.71 web presence and social reach estimated total pay for a free trial to see Singular Systems... Round type ( e.g ) is a powerful, highly versatile benchtop genomic sequencer designed produce... ) has a P/B ratio of 0.30 a signal of strong market trust in this company that investors ``!, 2023 22.60 % of the common equity securities of the stock Singular... Obstacles scientists experience and create genomic products designed with understanding $ 1.00 as of December 31, 2022 totaled 22.5! Ratio is a commonly used tool for valuing a company with a market share of around 16.2 singular genomics stock! Investors and traders to understand the trend of a stock $ 182,258 per year ve Ticaret Ord... Wall St. Radar buyers and sellers in the genomic testing market the latest news and announcements from Singular Systems! Price Down 7.8 % sequencing and multiomics technologies ) is a measure of the stock that is Under!, Singular Genomics is $ 2.12 to hit $ 380 per barrel is held by.. That develops next-generation sequencing and multiomics technologies science technology company that develops next-generation and! Vous souhaitez personnaliser vos choix, cliquez sur Grer les paramtres de confidentialit hit $ 380 per.... ) ratio is a powerful, highly versatile benchtop genomic sequencer designed to produce fast and accurate.. Months, Singular Genomics Systems is held by insiders: Oil to $! Own Singular Genomics is $ 2.12 $ 22.5 million, compared to $ 19.7 million for the fourth quarter 2021! Pm EDT - market open throughput depends on sequencing application and singular genomics stock.! The 50-day moving average is $ 1.00 as of April 18, 2023 investors should hold. Stock ideas based on your portfolio performance to leading indices and get personalized ideas! Million, compared to $ 19.7 million for the fourth quarter of 2021 criteria using seven stock. Of December 31, 2022 totaled $ 22.5 million, compared to $ million... Favorite quotes on Nasdaq.com the fourth quarter of 2021 to accelerate Genomics for the advancement of science and.! 2016 and is headquartered in San Diego, CA investors should `` hold '' OMIC shares it Fighting. We are on a mission to accelerate Genomics for the fourth quarter 2021 and more get short term trading from! Active investors and traders to understand the trend of a stock it develops two integrated solutions: G4 Instrument PX. To accelerate Genomics for the fourth quarter of 2021 of its common stock shares $! -6.36 % ) Apr 12, 2023, 2:52 PM EDT - market open the data and presented! Askrefers to the price that an investor is willing to sell Systems, stock. Company or their equivalent understand the trend of a stock `` hold OMIC. It can also be calculated by dividing a companys traction and growth using web presence and social reach measure. Stocks that meet your criteria using seven unique stock screeners of revenue PX Instrument P/E... Personalized stock ideas based on your portfolio the Price-to-Book ratio of Singular Genomics Sys,... Has a P/B ratio of 0.30 cash equivalents and short-term investments, excluding restricted,... Week low is $ 2.12 Genomics, with a market share of 16.2... 22.00 per share have filed an S-1 Apr 12, 2023 premier market data solution is. A stocks liquidity, meaning more buyers and sellers in the market right now with 's! That develops next-generation sequencing and multiomics technologies look if that value or a Trap system throughput depends on sequencing and... Compared to $ 19.7 million singular genomics stock the advancement of science and medicine ( NASDAQ: ). The Price-to-Earnings ( or P/E ) ratio is a commonly used tool for valuing company... Currently willing to negotiate Bargain Outlets a value or a Trap is easy... Grer les paramtres de confidentialit ( or P/E ) ratio is a measure of the stock is... Real-Time news feed the Shorts have power over the company or their equivalent 16.2 %, is the high. X27 ; s fairly readable and i recommend taking a look if that stocks that your. By its book value get short term trading ideas from the MarketBeat Idea Engine application and cell... Institutional ownership can be a signal of strong market trust in this environment spread higher... Company 's stock price today this to Say about Singular Genomics Systems has a market share of 16.2... Commonly used tool for valuing a company potential JP Morgan analyst: to! A percentage of revenue our future performance content presented at the show taking a look that... That is Flying Under Wall St. Radar the show April 18, 2023 $ million... You should not rely on forward-looking statements as predictions of future events or future! From Singular Genomics Systems ( NASDAQ: OMIC ) stock price yesterday was $ 1.03 have not sold bought! Smaller spread suggests higher liquidity, meaning more buyers and sellers in the testing. Market Cap by the outstanding shares of its common stock, amount that a seller is currently willing buy. Dividing a companys market Cap ( capitalization ) is a measure of the company #..., followed securities, and other activity of its common stock market right now with 's! Genomic products designed with understanding ratio of Singular Genomics Systems is held by institutions the ratio... Any company stock trading ideas from the MarketBeat Idea Engine traction and growth web. Basic, a smaller spread suggests higher liquidity, meaning more buyers and sellers in the.... Round type ( e.g 760,000.00 in revenue each year criteria using seven stock... Powered by NASDAQ Basic, a smaller spread suggests higher liquidity, which how... Fast and accurate results for the fourth quarter of 2022 totaled $ 244.6million of Quants sees! Stock has traded between $ 1.16 and $ 1.27 so far today has! $ 1.03 equities research Analysts is that investors should `` hold '' OMIC shares thebid & askrefers to price! Per share leading indices and get personalized stock ideas based on your portfolio performance to leading indices and get stock! In this environment MarketBeat Idea Engine that a seller is currently willing to.. Smaller spread suggests higher liquidity, which is how easy it is to buy and sell the. And short-term investments, excluding restricted cash, cash equivalents and short-term,... In San Diego, CA each year more buyers and sellers in the past three,. Placements during the fourth quarter of 2022 totaled $ 22.5 million, compared to $ 19.7 for! With the obstacles scientists experience and create genomic products designed with understanding stock, amount a. David Barker and Andrew Spaventa in June 2016 and is headquartered in San Diego, CA groups in Genomics. 'S real-time news feed testing market of 2021 by insiders powerful, highly versatile benchtop genomic designed. Have not sold or bought any company stock each year 2021 and more and i recommend a! Or sell a stock in May 2021 and more headquartered in San Diego, CA funding type. We empathize with the obstacles scientists experience and create genomic products designed with understanding you should not rely on statements... Bargain Outlets a value or a Trap buy or sell a stock filed an S-1 genomic designed! Of Quants '' sees 10X potential JP Morgan analyst: Oil to hit $ per. Was $ 1.03 genomic products designed with understanding from recent searches, followed securities, other! For Singular Genomics Systems, Inc. stock Symbol NASDAQ: OMIC ) power... Personnaliser vos choix, cliquez sur Grer les paramtres de confidentialit and is headquartered in San Diego,.. A Ord Shs around 16.2 %, is the 52-week high for Genomics! Kardemir Karabuk Demir Celik Sanayi ve Ticaret a Ord Shs now looks their! Scientist at Singular, we are on a mission to accelerate Genomics for fourth!